Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Has announcements
×
pexidartinib
×
Clear all
Filters
3
NCT02371369
2022-05-11
ENLIVEN
Daiichi Sankyo
Phase 3
Completed
120 enrolled
25 charts
1 FDA